Angiotensin II, RAS activation and RAS blockers in COVID-19: unambiguous evidence

N/A

Saved in:

Bibliographic Details
Main Authors:	Lorenzo A. Calò (Author), Lucia Federica Stefanelli (Author), Federico Nalesso (Author)
Format:	Book
Published:	Karger Publishers, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rãs
by: Maria de Fátima Sousa e Silva
Published: (2014)

Effect of ras-blockers and no-cycle metabolites on the renal functions of rats exposed to thyroxine injections
by: S. I. Dolomatov, et al.
Published: (2014)

Effect of ras-blockers and no-cycle metabolites on the renal functions of rats exposed to thyroxine injections
by: S. I. Dolomatov, et al.
Published: (2014)

Targeting active RAS with molecular glue
by: Wenjing Su, et al.
Published: (2024)

RAS ACADEMICIANS AND CORRESPONDING MEMBERS OF RAS ELECTED BY THE GENERAL MEETING OF MEMBERS OF RAS ON OCTOBER 27-28, 2016 BY DEPARTMENTS OF PHYSIOLOGY AND MEDICINE
by: article editorial
Published: (2017)

RAS ACADEMICIANS AND CORRESPONDING MEMBERS OF RAS ELECTED BY THE GENERAL MEETING OF MEMBERS OF RAS ON OCTOBER 27-28, 2016 BY DEPARTMENTS OF PHYSIOLOGY AND MEDICINE
by: article editorial
Published: (2017)

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
by: Paweletz Cloud, et al.
Published: (2010)

The Fate of Bacteriophages in Recirculating Aquaculture Systems (RAS)-Towards Developing Phage Therapy for RAS
by: Gabriel M.F. Almeida, et al.
Published: (2019)

Regulation of Ras Signaling by S-Nitrosylation
by: Sónia Simão, et al.
Published: (2023)

RAS pathway regulation in melanoma
by: Amira Al Mahi, et al.
Published: (2022)

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
by: Jingwei Bian, et al.
Published: (2021)

Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
by: Sungha Park, et al.
Published: (2020)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012)

Incidental Abnormalities in Oral Mucosal Carcinogenesis of v-H-ras Transgenic Mice OF v-H-ras TRANSGENIC MICE
by: Dewi Agustina
Published: (2012)

Functional distinction in oncogenic Ras variant activity in Caenorhabditis elegans
by: Haimeng Lyu, et al.
Published: (2024)

Oncogenic RAS-dependent Reprogramming of Cellular Plasticity
Published: (2020)

In memoriam of academician of the RAS Yu.K. Skripkin
by: Editorial Article
Published: (2017)

Current and future use of angiotensin II receptor blockers in patients with COVID-19
by: A. V. Matveev, et al.
Published: (2020)

Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
by: Fiona M. Healy, et al.
Published: (2024)

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice
by: Nerea Martos-Guillami, et al.
Published: (2024)

Gitelman's and Bartter's syndromes: from genetics to the molecular basis of hypertension and more
by: Verdiana Ravarotto, et al.
Published: (2022)

Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies
by: Verdiana Ravarotto, et al.
Published: (2022)

Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators
by: Yuran Qiu, et al.
Published: (2021)

Mechanistic Insight on Ras Inhibition Strategies in Cancer Therapy
by: Jeiran Pashapour-Anousheh, et al.
Published: (2022)

Placental Ras Regulates Inflammation Associated with Maternal Obesity
by: Stella Liong, et al.
Published: (2018)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
by: Hany A Al-Hussaniy, et al.
Published: (2023)

Inhibition of colon cancer K-RasG13D mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway
by: Yan Qi, et al.
Published: (2022)

POSISI GIGI DIPENGARUHI OLEH FAKTOR RAS (STUDI PUSTAKA)
by: Himawan Halim, et al.
Published: (2015)

Chickenpox prevention behaviour in the Ras Laffan Industrial City Qatar
by: Djuhari Djuhari
Published: (2020)

RAS and beyond: the many faces of the neurofibromatosis type 1 protein
by: Corina Anastasaki, et al.
Published: (2022)

RAS-mediated tumor stress adaptation and the targeting opportunities it presents
by: Alexandra Redding, et al.
Published: (2022)

Understanding and drugging RAS: 40 years to break the tip of the iceberg
by: Donita C. Brady, et al.
Published: (2022)

The use of renin-angiotensin system blockers in patients with COVID-19
by: Anton V. Rodionov
Published: (2021)

Revolusi penilaian dalam sistem pemantauan pelajar (i-RAS) (Revolution on assessment for student monitoring system (i-RAS) / Mohd Samsudin Abdul Hamid ...[et al.]
by: Abdul Hamid, Mohd Samsudin, et al.
Published: (2020)

No mutations found in exons of TP53, H-RAS and K-RAS genes in liver of male Wistar rats submitted to a medium-term chemical carcinogenesis assay
by: Erick da Cruz Castelli, et al.
Published: (2002)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021)

A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders
by: Maria Rita Gulotta, et al.
Published: (2021)

APOPTOSIS EN CÉLULAS MAMARIAS TRANSFECTADAS CON EL ONCOGEN ras
by: Ricardo Cornejo U
Published: (2007)

Evaluation of serum zinc levels in patients with recurrent aphthous stomatitis (RAS)
by: Zuzanna Ślebioda, et al.
Published: (2017)

EXPRESIÓN DE LAS PROTEÍNAS p21 RAS y CÁNCER
by: Otmara Guirado Blanco
Published: (2011)